Perampanel is a selective noncompetitive AMPA-type glutamate receptor antagonist which has demonstrated anticonvulsant activity in experimental seizure models and antiepileptic activity in clinical trials.
More Information Supplier PageNG52 is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 _mu_M), and the related Pho85p kinase (IC50 = 2 _mu_M).
More Information Supplier PageNG52 is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 _mu_M), and the related Pho85p kinase (IC50 = 2 _mu_M).
More Information Supplier PageNG52 is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 _mu_M), and the related Pho85p kinase (IC50 = 2 _mu_M).
More Information Supplier PageSQ109 is an orally active, small molecule antibiotic for treatment of pulmonary T(tuberculosis).
More Information Supplier PageSQ109 is an orally active, small molecule antibiotic for treatment of pulmonary T(tuberculosis).
More Information Supplier PageSQ109 is an orally active, small molecule antibiotic for treatment of pulmonary T(tuberculosis).
More Information Supplier PageVS-5584 is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
More Information Supplier PagePerampanel is a selective noncompetitive AMPA-type glutamate receptor antagonist which has demonstrated anticonvulsant activity in experimental seizure models and antiepileptic activity in clinical trials.
More Information Supplier PageABT-199 is a so-called BH3-mimetic drug, which is designed to block the function of the protein Bcl 2.
More Information Supplier Page
